Zeke Ashton

Zeke Ashton


Recent articles

When Good Companies Get Bad Breaks

Emotion is a part of the investing game and can be hard to master when a favorite company falls on hard times.

Are Biotechs Worth the Risk?

Even when their drugs are doing well, companies in this industry don't necessarily yield big rewards for investors.

Beautiful, Not Boring

Look for solid performers that lack a natural buying constituency.

King Makes a Comeback

The love/hate cycle might be ready to shift again for this pharmaceutical.

A Stamps.com of Approval

The online postal purveyor announces a reverse split and a huge dividend.

A Big Win for the Little Guy

Zeke Ashton trusts Utah Medical will find a good use for a well-deserved windfall.

Dell's Hollow Buybacks

As Zeke Ashton explains, buybacks don't always serve shareholders.

The Lessons of Moneyball

Great portfolios and winning ball clubs have more in common than you think.

Kinder Morgan Steps Up

Zeke Ashton praises the energy company's shareholder-centric management team.